SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Roger Cranwill who wrote (1189)8/8/1997 10:10:00 AM
From: Roudy   of 1762
 
Hi Roger, I think we are still all out here. Just not much to post about lately. Hopefully, we will soon hear about a formal approval on C2B8 from the FDA. Also, we should be hearing if CE9.1 will be terminated or reinstated under the next generation of it. I believe this is why the stock has not gone anywhere. Alot of the risk has been removed with the unanimous approval from the FDA review panel. IMO, it is just a matter of time before this stock starts advancing. Don
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News